T2′ imaging indicates decreased tissue metabolism in frontal white matter of MS patients

Multiple Sclerosis

Volumn 15, Issue 6, 2009, Pages 701-707

  Holst, Brigitte ^a   Siemonsen, S ^a   Finsterbusch, J ^a   Bester, M ^a   Schippling, S ^a   Martin, R ^a   Fiehler, J ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Gray matter; Iron; MRI; Multiple sclerosis; Quantitative imaging measure; White matter

Indexed keywords

ADULT; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; THALAMUS; WHITE MATTER; FOREBRAIN; METABOLISM; MIDDLE AGED; MYELINATED NERVE; NERVE CELL; PATHOLOGY;

IRON;

ADULT; CAUDATE NUCLEUS; FEMALE; FRONTAL LOBE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; NEURONS; PROSENCEPHALON; THALAMUS; YOUNG ADULT;

EID: 66149165910     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509103713     Document Type: Article

References (37)

1. Rovira, A, Alonso, J, Cucurella, G, et al. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images. AJNR Am J Neuroradiol 1999; 20: 1939-1945.
2. Miller, DH. Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis. NeuroRx 2004; 1: 284-294.
3. Barkhof, F, van Walderveen, M. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1675-1686.
4. Jasperse, B, Minneboo, A, de Groot, V, et al. Determinants of cerebral atrophy rate at the time of diagnosis of multiple sclerosis. Arch Neurol 2007; 64: 190-194.
5. Chard, DT, Griffin, CM, McLean, MA, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125(Pt 10): 2342-2352.
6. Law, M, Saindane, AM, Ge, Y, et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: Perfusion MR imaging findings in normal-appearing white matter. Radiology 2004; 231: 645-652.
7. Inglese, M, Liu, S, Babb, JS, Mannon, LJ, Grossman, RI, Gonen, O. Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS. Neurology 2004; 63: 170-172.
8. Inglese, M, Park, SJ, Johnson, G, et al. Deep gray matter perfusion in multiple sclerosis: Dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 2007; 64: 196-202.
9. Zhang, Y, Zabad, RK, Wei, X, Metz, LM, Hill, MD. Mitchell, JR. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler 2007; 13: 880-883.
10. Rashid, W, Parkes, LM, Ingle, GT, et al. Abnormalities of cerebral perfusion in multiple sclerosis. J Neurol Neurosurg Psychiatry 2004; 75: 1288-1293.
11. An, H, Lin, W. Quantitative measurements of cerebral blood oxygen saturation using magnetic resonance imaging. J Cereb Blood Flow Metab 2000; 20: 1225-1236.
12. Geisler, BS, Brandhoff, F, Fiehler, J, et al. Bloodoxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke 2006; 37: 1778-1784.
13. Calamante, F, Lythgoe, MF, Pell, GS, et al. Early changes in water diffusion, perfusion, T1, and T2 during focal cerebral ischemia in the rat studied at 8.5 T. Magn Reson Med 1999; 41: 479-485.
14. Ding, XQ, Kucinski, T, Wittkugel, O, et al. Normal brain maturation characterized with age-related T2 relaxation times: An attempt to develop a quantitative imaging measure for clinical use. Invest Radiol 2004; 39: 740-746.
15. Brass, SD, Benedict, RH, Weinstock-Guttman, B, Munschauer, F, Bakshi, R. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006; 12: 437-444.
16. Roelcke, U, Kappos, L, Lechner-Scott, J, et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurology 1997; 48: 1566-1571.
17. Derache, N, Marie, RM, Constans, JM, Defer, GL. Reduced thalamic and cerebellar rest metabolism in relapsing-remitting multiple sclerosis, a positron emission tomography study: Correlations to lesion load. J Neurol Sci 2006; 245: 103-109.
18. Stankiewicz, J, Panter, SS, Neema, M, Arora, A, Batt, CE, Bakshi, R. Iron in chronic brain disorders: Imaging and neurotherapeutic implications. Neurotherapeutics 2007; 4: 371-386.
19. Neema, M, Stankiewicz, J, Arora, A, et al. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 2007; 17(Suppl. 1): 16S-21S.
20. Bakshi, R, Shaikh, ZA, Janardhan, V. MRI T2 shortening ('black T2') in multiple sclerosis: Frequency, location, and clinical correlation. Neuroreport 2000; 11: 15-21.
21. Bakshi, R, Dmochowski, J, Shaikh, ZA, Jacobs, L. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001; 185: 19-26.
22. Bakshi, R, Benedict, RH, Bermel, RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: A quantitative magnetic resonance imaging study. Arch Neurol 2002; 59: 62-68.
23. Ge, Y, Jensen, JH, Lu, H, et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007; 28: 1639-1644.
24. Bermel, RA, Puli, SR, Rudick, RA, et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005; 62: 1371-1376.
25. Schenck, JF, Zimmerman, EA. High-field magnetic resonance imaging of brain iron: Birth of a biomarker? NMR Biomed 2004; 17: 433-445.
26. LeVine, SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 1997; 760: 298-303.
27. Bakshi, R, Miletich, RS, Kinkel, PR, Emmet, ML, Kinkel, WR. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging 1998; 8: 228-234.
28. Blinkenberg, M, Jensen, CV, Holm, S, Paulson, OB, Sorensen, PS. A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS. Neurology 1999; 53: 149-153.
29. Siemonsen, S, Finsterbusch, J, Matschke, J, Lorenzen, A, Ding, XQ, Fiehler, J. Age-Dependent Normal Values of T2* and T2′ in Brain Parenchyma. AJNR Am J Neuroradiol 2008.
30. Blinkenberg, M, Rune, K, Jensen, CV, et al. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology 2000; 54: 558-564.
31. Paulesu, E, Perani, D, Fazio, F, et al. Functional basis of memory impairment in multiple sclerosis: A [18F]FDG PET study. Neuroimage 1996; 4: 87-96.
32. Miller, DH, Johnson, G, Tofts, PS, MacManus, D, McDonald, WI. Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease. Magn Reson Med 1989; 11: 331-336.
33. Laule, C, Vavasour, IM, Moore, GR, et al. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study. J Neurol 2004; 251: 284-293.
34. Whittall, KP, MacKay, AL, Li, DK, Vavasour, IM, Jones, CK, Paty, DW. Normal-appearing whitematter inmultiple sclerosis has heterogeneous, diffusely prolonged T(2). Magn Reson Med 2002; 47: 403-408.
35. Tozer, DJ, Davies, GR, Altmann, DR, Miller, DH, Tofts, PS. Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysis. Magn Reson Med 2005; 53: 1415-1422.
36. Pozzilli, C, Fieschi, C, Perani, D. N, et al. Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis. J Neurol Sci 1992; 112: 51-57.
37. Miller, DH, Grossman, RI, Reingold, SC, McFarland, HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998; 121(Pt 1): 3-24.